KARINA SALOMON: Open Payments
NPI 1174144075 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 16 payments from 11 companies in 2025. Trend: 2023 $489 · 2024 $97 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $181 |
| Pharmacosmos Therapeutics Inc. | 2 | $146 |
| GENZYME CORPORATION | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $131 |
| Syndax Pharmaceuticals, Inc. | 1 | $119 |
| Incyte Corporation | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: SARCLISA, ENHERTU, TALZENNA, COSELA, JAKAFI, IBRANCE, HYQVIA, MONJUVI.
Industry payments across HI — which companies pay providers there.
